Monday, October 26, 2026
Home Authors Posts by Ogkologos

Ogkologos

4381 POSTS 0 COMMENTS

Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small...

Ogkologos -
0

Adding Abiraterone to ADT and Docetaxel Improves Survival in Metastatic Prostate...

Ogkologos -
0

A glucometer for cancer: towards a scalable, universal residual disease measurement

Ogkologos -
0

Consensus-Defined Weight Loss Episodes Arise in Discrete Intervals, Are Enriched Around...

Ogkologos -
0

ESMO launches new principles for humanising scientific reporting to strengthen the...

Ogkologos -
0

Clinical Activity of Talazoparib Plus Enzalutamide Demonstrated in Patients with High-Volume...

Ogkologos -
0

FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma

Ogkologos -
0

Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and...

Ogkologos -
0

Meet the first recipient of the ESMO Artificial Intelligence Fellowship

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Senaparib

Ogkologos -
0
123...439Page 1 of 439

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com